Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Tocilizumab
Tocilizumab
Routinely available
SMC (SMC2552)
02/10/2024

Indication

Treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. Refer to local guidelines

Treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. Refer to local guidelines

Therapeutic Area

Infections

Status Description

Routinely available in line with local or regional guidance

Formulation

20mg/ml concentrate for solution for infusion

Comments

Fife Therapeutic Treatment Guidelines for Patients with Covid 19 (Adults) - https://nhsfife.joinblink.com/#/hub/f1881252-32d2-4c7c-be82-89c0d8a01561 Lothian: Hospitalised patients - https://rightdecisions.scot.nhs.uk/antimicrobial-prescribing-nhs-lothian/body-systems/respiratory-infections/covid-19-drug-treatments-in-hospitalised-adult-patients/ Lothian Community Patients - https://apps.nhslothian.scot/refhelp/guidelines/covid-19/communitytreatmentsforultrahighriskpatients/ For Borders refer to national guidance.

Link to Advice

SMC2552

Advice Published

29/03/2023

SMC Submission Type

Collaboration

SMC Status

Accepted